-
US average diesel price rises to record $5.90 a gallon: AAA
-
Fury claims Joshua bout is off, calls for Usyk trilogy
-
Dukascopy Bank Unveils AI-Powered Trading, 25,000+ Stock CFDs and a New Flagship E-Banking App
-
British family bids to row back against suicide taboo
-
Tech firms rally but Asian markets mixed, with eyes on US inflation
-
China's teenage 223cm basketball player 'just a little girl'
-
Nepal holds day of mourning as families pray missing still alive
-
Tokyo's Shinjuku to ban more than half of vacation rentals
-
African players in Europe: Mbeumo fires solo goal as United draw
-
Australian Rules limits contact training to reduce concussion
-
Malaysia cancels haze emergency, but warns problems remain
-
Germany's Merz under pressure from far-right election triumph
-
Philippine sensation Eala looks forward to Asian Games 'fun'
-
Nepal tunnel rescues face 'unprecedented' challenge
-
Jakarta airport extends closure after volcano eruption
-
Mourinho's Real Madrid European revival bid starts with Inter reunion
-
Lonely woman director in Venice sees industry backsliding on gender
-
Solomons PM survives attempt to oust government
-
Tech firms rally on mixed day for Asian markets, with eyes on US inflation
-
Ohtani 'unlikely' to pitch again this season, says Dodgers manager
-
World number one An sends Asian Games warning with China hat-trick
-
Driver thanks 'superhero' rival for saving him from flaming race car
-
PSG go for three in a row as Champions League returns
-
Can dogs sniff cancer? AI joins the hunt in India
-
"Super-human' Alcaraz books US Open quarter-final clash with Shelton
-
Shelton steams into US Open quarter-final clash with Alcaraz
-
ECB set to hike interest rates as Iran war flares anew
-
25 years on, America seeks to keep 9/11 memories alive
-
AI data centers are less thirsty now, tech giants say
-
'Trumpapalooza' tests Republican bet on unpopular US president
-
North Korea vows nuclear-armed navy as US ally drills open
-
Pegula tops Cirstea to reach US Open quarter-finals
-
Under-fire Labuschagne named in Australia Test squad for South Africa
-
Australians could opt out of social media algorithms under new law
-
Enjoying the moment: Alcaraz steps it up to reach US Open quarter-finals
-
Tiafoe tops Medvedev in straight sets at US Open
-
Five dead, five injured after Amazon cargo plane overshoots Miami runway
-
Zverev seeks US Open last eight as Osaka faces Rybakina
-
La Rochelle half-backs lead fightback against Toulouse
-
Alcaraz turns up heat to reach US Open quarters
-
US envoys have 'more effective proposals': Ukraine official
-
Gatti salvages Juve draw with AC Milan in Serie A
-
Defending champion Alcaraz powers into US Open quarter-finals
-
Sinayoko stars as unbeaten Paris FC down Marseille
-
Amazon cargo plane overshoots Miami runway, hits vehicles, catches fire
-
Still on top: 'Spider-Man' dominates North American box office
-
Toll from Yemen clashes passes 300 as civilians flee homes
-
Zelensky in fresh talks with US envoys: Ukraine official
-
Sabalenka books US Open quarter-final clash with Noskova
-
Noskova edges Kostyuk to reach US Open quarter-finals
Can dogs sniff cancer? AI joins the hunt in India
When rescue dog Chloe is not tumbling across the grass on a farm outside India's tech capital Bengaluru, she is learning to sniff human breath for cancer with a little help from AI.
Fitted with a 3D-printed helmet and harness packed with sensors, Chloe is part of experimental efforts to use dogs' extraordinary sense of smell to develop a non-invasive test for the disease.
A growing body of global research suggests dogs can be trained to detect cancer and other human illnesses, from Parkinson's to Covid-19.
The Bengaluru-based startup Dognosis is using AI to analyse dogs' brain activity, respiration and body language -- turning their reaction to scent into data.
"In an hour, they can do thousands of sniffs," co-founder Akash Kulgod, 26, told AFP. "Each sniff can evaluate a sample."
Dognosis hopes to launch commercially next year, which it says would make it the third company of its kind, after firms from Germany and Israel.
Early detection can make a crucial difference to cancer survival rates, but in India many patients are diagnosed only after the disease has advanced.
Dog sniffs could provide an easy and affordable first layer of screening to be deployed at scale, finding potential cases for further testing.
As it chases commercial approval, Dognosis -- backed by venture-capital firms including Accel India -- is collaborating with government medical institutions for its research.
Chloe, a Labrador mix, is one of 15 dogs being coached by the startup, clad in customised data-gathering helmets.
"It's like a doggy 'Iron Man' suit," said Kulgod, who comes from a family of doctors and studied cognitive science at the University of California, Berkeley.
- 'Promising' study -
Research suggests diseases can alter the chemicals released by the body, creating distinctive odours.
Dogs have around 300 million scent receptors, compared to about five million in humans.
The testing method is simple: a patient breathes into a cotton mask for about 10 minutes, and the mask is then sealed in a bag and taken to the lab. Patients do not meet the dogs.
A recent Dognosis study of more than 1,500 participants, involving six hospitals in Karnataka state, was published in the Journal of Clinical Oncology.
The company said it achieved an accuracy rate of more than 90 percent across seven major types of cancer, and now plans to test in real-world programmes.
Cancer specialists in Bengaluru independent of the project voiced cautious optimism.
"The study is promising, as an early signal," said Santhosh Kumar Devadas, head of oncology at Ramaiah Memorial Hospital.
"But they need to do the study with a much larger group before we make any definitive conclusions."
Neelesh Reddy, a senior consultant oncologist at Manipal Hospitals, told AFP that "only time will tell how this technology will be useful to the actual patients".
- Dog 'work-life balance' -
India has described cancer as a major public health concern, saying one in nine of its 1.4 billion people are likely to develop the disease.
Dognosis says it aims to improve "proactive and preventative medicine" while boosting "human-canine communication".
Most of the dogs are beagles, along with some Malinois and Shepherd mixes, brought on board through adoption or legal breeders.
But only the best are selected, said Kulgod. The dog team individually lists each animal on the company website as an official "sniffer", alongside their photographs.
All have a great "work-life balance", with work time limited to around 30-45 minutes a day, he added.
At a centre called "Sniffspace", dogs test human samples on platforms equipped with automatic feeders dispensing dog treats.
Kulgod's co-founder Itamar Bitan, 28, who spent four years in an Israeli special-forces canine unit, said the dogs were trained using "positive reinforcement" to detect a "specific funky smell" for a reward.
"Some of the dogs run directly to the feeder expecting rewards, some dogs freeze, some dogs will scratch the sample with excitement," Bitan said.
"But, as long as the machine that learns how the dogs react to the sample is very consistent... we don't really mind."
T.Germann--VB